Neuroenhancers, addiction and research ethics

Area of Science:

• Neuroscience and Bioethics
• Philosophy of Technology

Background:

• Critiques of cognitive enhancement (CE) by Heinz et al. question the safety of neuroenhancing drugs and the ethical considerations of CE research.
• Heinz et al. argue that proponents of CE make unjustified assumptions regarding drug safety and ethical research practices.

Purpose of the Study:

• To critically evaluate the assumptions made by Heinz et al. regarding cognitive enhancement.
• To argue that the assumptions concerning the safety of neuroenhancing drugs and the ethicality of CE research are, in fact, justified.
• To identify and analyze the assumptions within the critique of cognitive enhancement.

Main Methods:

• Philosophical argumentation and ethical analysis.
• Deconstruction of arguments presented by Heinz et al.
• Re-evaluation of ethical concerns and safety considerations in cognitive enhancement.

Main Results:

• The assumptions that neuroenhancing drugs will be safe and that CE research poses no unique ethical problems are deemed correct.
• Heinz et al.'s arguments are shown to rely on assumptions that undermine their own critique.
• While CE raises ethical concerns, safety and research do not present unique difficulties compared to other scientific endeavors.

Conclusions:

• Proponents' assumptions regarding the safety and ethical research of cognitive enhancement are valid.
• The critique by Heinz et al. is flawed due to its own underlying assumptions.
• Ethical considerations for cognitive enhancement are manageable and do not represent unprecedented challenges.